31 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
and reimbursement, paid time off, and family leave.
INCREASING DIVERSITY AND INCLUSION IN CLINICAL TRIAL RECRUITMENT
We strive to increase diversity
8-K
EX-99.2
qi0 fwvhxpy2
17 Oct 22
Results support potential clinically meaningful activity of fosgonimeton without background therapy and mitigate program risk
8:30am
8-K
EX-99.1
76z5iflh07nlfce4fyb
15 Aug 22
Athira Pharma Reports Second Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
4:35pm
8-K
EX-99.2
jmxgkn p3gn
22 Jun 22
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
7:05am
8-K
EX-99.1
pnipcazhhs5
12 May 22
Athira Pharma Reports First Quarter 2022 Financial Results
4:12pm
DEFA14A
dnv dfqkxefhli4cf
26 Apr 22
Additional proxy soliciting materials
8:11am
DEFA14A
4qrzy39pvf53m zf
11 Apr 22
Additional proxy soliciting materials
4:36pm
8-K
EX-99.1
7axkmbfx
24 Mar 22
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
4:11pm